By Research and Markets (http://www.researchandmarkets.com/research/98qtr9/3_catalysts_to) has announced the addition of the "3 Catalysts To Catapult Global Coronary Stent Market To $13 Billion" report to their offering.
The global coronary stent market is expected to be over $13 billion by 2019, despite the current downward trend in the US, the largest market, and declining selling prices globally.
Increasing PCI (percutaneous coronary intervention) procedures triggered by the rising prevalence of CAD (coronary artery disease), novel technologies in pipeline addressing the unmet needs, uptake of Bioabsorbable stents and impressive growth in APAC region have the potential to upswing the fortunes of the market that has remained stagnant for a few years.
The market study takes into account various global clinical studies and pipeline products and it suggests that the coronary stent pipeline is clustered with new generation Drug Eluting Stent (DES), bioactive stents, bioabsorbable technology and stents for the niche segments such as complex and bifurcated vessels. Altering the trend, small to medium size companies from the developing economies are ambitiously conducting clinical studies to win the approvals and expand the use of devices for new indications.
The stent market globally and in the developed nations is largely controlled by three players - Abbott Laboratories, Boston Scientific, and Medtronic. While in developing economies, small and medium players from Asia and Europe have a considerable share in terms of volume.
This comprehensive, 465 page global strategic business report is authored by a team of sector analysts who used rigorous primary and secondary research and robust analytical models to provide strategic insight and to forecast for all major stent types BMS, DES, Bioabsorbable stents in leading 23 geographies.
Data at global, continents, economic zones, and country level:
- Market size of coronary stents in terms - value and volume (2005-2019) for BMS, DES and Bioabsorbables (Bioresorbable - BVS)
- Market growth rates (2005-2019)
- Average prices of various stents in all the covered geographies (2005-2019)
- Number of PCI procedures
- Analytical comparison between different continents and economic regions
- Market dynamics - market trends, drivers, restrains, issues, competitive landscape
- Detailed pipeline and clinical studies
- Product approval status - major geographies
- Industry consolidation, partnerships, product launches, approvals and recalls
- Detailed company profiles of around 70 companies from different levels of value chain
Key Topics Covered:
1. Charts & Tables
2. Executive Summary
3. Market at a Glance
4. Introduction to Stents
5. Coronary Stents
6. Types of Stents
7. Approvals
8. Competitive Landscape
9. Clinical Studies
10. Coronary Stents - Market Drivers and Restrains
11. Overview: Market trends
12. Approvals Driving the Growth
13. Market Data
14. Company Profiles
15. Recent Events
16. Appendix
17. Research Methodology
18. Disclaimer
Companies Mentioned Include:
- Abbott Vascular
- Alvimedica Medical Technologies
- Arterial Remodeling Technologies
- Boston Scientific Corporation
- Biosensors International
- Biotronik SE & Co.kG
- CID S.r.l.
- Clearstream Technologies Ltd.
- Disa Vascular (Pty) Ltd.
- Elixir Medical Corporation
- Endocor Gmbh
- Essen Technology (Beijing) Co., Ltd
- Hexacath
- Iberhospitex S.A
- InspireMD, Inc.
- Japan Stent Technology Co., Ltd.
- Kyoto Medical
- Lepu Medical Technology Co., Ltd.
- Medinol
- Medtronic, Inc.
- Meril Life Sciences Pvt. Ltd.
- Micell Technologies, Inc.
- MicroPort Scientific Corporation
- Minvasys
- OrbusNeich
- Relisys Medical Devices Limited
- Terumo Medical Corporation
- Translumina
- Tryton Medical
- Vascular Concepts
For more information visit http://www.researchandmarkets.com/research/98qtr9/3_catalysts_to
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical
Devices
